First Manhattan’s Covidien COV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
– Sell
-650,358
Closed -$66.5M – 1589
2014
Q4
$66.5M Sell
650,358
-16,530
-2% -$1.59M 0.38% 55
2014
Q3
$57.7M Sell
666,888
-424,079
-39% -$37.6M 0.34% 58
2014
Q2
$98.4M Buy
1,090,967
+337,242
+45% +$25.2M 0.62% 37
2014
Q1
$55.5M Buy
753,725
+107,735
+17% +$7.51M 0.37% 60
2013
Q4
$44M Buy
645,990
+2,887
+0.4% +$188K 0.29% 70
2013
Q3
$39.2M Buy
643,103
+540
+0.1% +$32.9K 0.27% 69
2013
Q2
$39M Hold
642,563
– – 0.27% 72

First Manhattan's COV Position: Q1 2015 in Review

First Manhattan sold out of Covidien (COV) in Q1 2015, closing a stake of 650,358 shares — an estimated $66.5M sold.

First Manhattan first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $98.4M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • First Manhattan reported no remaining Covidien position as of Q1 2015 after selling out during the quarter.
  • First Manhattan sold 650,358 Covidien shares in Q1 2015, an estimated $66.5M.
  • First Manhattan first reported a position in Covidien in Q2 2013 and held it in 7 quarters.
  • First Manhattan's Covidien position peaked at $98.4M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held Covidien as of Q1 2015.

Based on First Manhattan's 13F filing for Q1 2015, filed 30 Apr 2015.